Dr. Imperial joined HepQuant as Chief Medical Officer in March 2025. Prior to her full-time role, she served on the company’s Scientific Advisory Board and contributed as a consultant and... read more →
Touraj Shokati, PhD, joined HepQuant in May 2024 as Vice President of Clinical Laboratory Affairs, where he oversees clinical laboratory operations and ensures compliance with regulatory guidelines. Prior to this,... read more →
Joellyn Enos is an experienced diagnostics leader specialized in commercial strategy, go-to-market planning, product launch, business operations, and development for IVD and LDT diagnostic tests for health providers and patients. ... read more →
Brad Everson joined HepQuant in 2009 and serves as the Chief Business Development Officer. Mr. Everson is responsible for overseeing HepQuant's Pharma Solutions business as well as strategic business development... read more →
Paige Nardi, MBA, joined the Company in June 2023 as Vice President of Market Access, with responsibility for reimbursement, billing and market access. Ms. Nardi was Executive Director of Market... read more →
Randy Dietrich is president of HepQuant. With responsibility for commercialization and capitalization, Mr. Dietrich has been one of the major financial backers of HepQuant and has been active in its... read more →
Dr. Everson founded HepQuant in 2007 and has served as Chief Executive Officer of HepQuant since its inception. He was Professor of Medicine and Director of Hepatology at the University... read more →